title: Clinical assessment of the warming sensation accompanying flavor 316282 in a cold and cough syrup containing paracetamol, phenylephrine hydrochloride, and guaifenesin.
abstract: OBJECTIVE
  The primary objective was to assess the warming sensation caused by flavor 316282 in a cold and cough product in the target population.
  
  
  METHODS
  A single-cohort, single-treatment arm, open-label study. Subjects received one 30-mL dose of syrup containing flavor 316282, paracetamol, phenylephrine hydrochloride, and guaifenesin and recorded onset and disappearance of any warming sensation in the mouth/throat. Subjects' assessment of strength and appeal of the sensation, taste, texture, and acceptability of the product as a cold and cough remedy was investigated using questionnaires.
  
  
  RESULTS
  A total of 51 subjects were included; 47 (92.1%) experienced a warming sensation. The median duration of the warming sensation was 100 s (95% confidence interval = 82 s, 112 s). The majority of subjects rated the syrup as excellent, good, or fair for treatment of cough and cold symptoms (96.1%), taste (80.4%), and texture (98.0%). There were no safety concerns, and the syrup was well tolerated. Most subjects liked the warming sensation.
  
  
  CONCLUSIONS
  Flavor 316282 in a cold and cough syrup is associated with a warming sensation. The syrup is well tolerated, safe, and palatable.
authors.affiliation: Novartis Consumer Health S.A., Nyon, Switzerland.
authors.forename: Rowland
authors.initials: R
authors.lastname: Furcha
authors.affiliation: Novartis Consumer Health S.A., Nyon, Switzerland.
authors.forename: Joëlle
authors.initials: J
authors.lastname: Monnet
keywords: Flavor 316282; cold; cough; syrup; warming